Enda Kenny (Mayo, Fine Gael) | Oireachtas source

-----which is completely independent in the way it judges the improvement in the quality of life for any drug to be given to any patient – and I regret of course, and sympathise with those, where the death of anybody has occurred, never mind children – undertook the assessment of Orkambi and noted that the drug was not considered cost-effective at a price of €160,000 per patient per year as submitted by the manufacturer.

See this speech in context